Trial · NCT00103857
Adverse events833
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
1 to 20 of 833
Download this page as JSON| Type | Event | Organ system | Group | Affected | At risk | Events |
|---|---|---|---|---|---|---|
| other | Any Gastrointestinal Disorders | Gastrointestinal disorders | Sitagliptin 100 mg q.d. | 19 | 179 | |
| other | Any Gastrointestinal Disorders | Gastrointestinal disorders | Metformin 500 mg b.i.d. | 23 | 182 | |
| other | Any Gastrointestinal Disorders | Gastrointestinal disorders | Metformin 1000 mg b.i.d. | 42 | 182 | |
| other | Any Gastrointestinal Disorders | Gastrointestinal disorders | Sitagliptin 50 mg b.i.d. + Metformin 500 mg b.i.d. | 31 | 190 | |
| other | Any Gastrointestinal Disorders | Gastrointestinal disorders | Sitagliptin 50 mg b.i.d + Metformin 1000 mg b.i.d. | 35 | 182 | |
| other | Any Gastrointestinal Disorders | Gastrointestinal disorders | Placebo/Metformin 1000 mg b.i.d. | 17 | 176 | |
| other | Any Gastrointestinal Disorders | Gastrointestinal disorders | Sitagliptin 50 mg b.i.d + Metformin 1000 mg b.i.d. OLC | 18 | 117 | |
| other | Constipation | Gastrointestinal disorders | Sitagliptin 100 mg q.d. | 9 | 179 | |
| other | Constipation | Gastrointestinal disorders | Metformin 500 mg b.i.d. | 6 | 182 | |
| other | Constipation | Gastrointestinal disorders | Metformin 1000 mg b.i.d. | 6 | 182 | |
| other | Constipation | Gastrointestinal disorders | Sitagliptin 50 mg b.i.d. + Metformin 500 mg b.i.d. | 7 | 190 | |
| other | Constipation | Gastrointestinal disorders | Sitagliptin 50 mg b.i.d + Metformin 1000 mg b.i.d. | 3 | 182 | |
| other | Constipation | Gastrointestinal disorders | Placebo/Metformin 1000 mg b.i.d. | 3 | 176 | |
| other | Constipation | Gastrointestinal disorders | Sitagliptin 50 mg b.i.d + Metformin 1000 mg b.i.d. OLC | 5 | 117 | |
| other | Diarrhoea | Gastrointestinal disorders | Sitagliptin 100 mg q.d. | 8 | 179 | |
| other | Diarrhoea | Gastrointestinal disorders | Metformin 500 mg b.i.d. | 14 | 182 | |
| other | Diarrhoea | Gastrointestinal disorders | Metformin 1000 mg b.i.d. | 23 | 182 | |
| other | Diarrhoea | Gastrointestinal disorders | Sitagliptin 50 mg b.i.d. + Metformin 500 mg b.i.d. | 19 | 190 | |
| other | Diarrhoea | Gastrointestinal disorders | Sitagliptin 50 mg b.i.d + Metformin 1000 mg b.i.d. | 25 | 182 | |
| other | Diarrhoea | Gastrointestinal disorders | Placebo/Metformin 1000 mg b.i.d. | 12 | 176 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT00103857/events